未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor- blinded phase IV study (IMMpulse) Gold, Linda F. Stein; Bagel, Jerry; Tyring, Stephen K.; Hong, H. Chih-ho; Pavlovsky, Lev; Vender, Ronald; Pinter, Andreas; Reich, Adam; Drogaris, Leonidas; Wu, Tianshuang; Patel, Manish; Soliman, Ahmed M.; Photowala, Huzefa; Stakias, Vassilis; Richter, Sven; Papp, Kim A. 分享 收藏
分享 收藏
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study Sofen, Howard; Bissonnette, Robert; Yosipovitch, Gil; Silverberg, Jonathan I.; Tyring, Stephen; Loo, Wei Jing; Zook, Matthew; Lee, Mark; Zou, Liangxing; Jiang, Guang-Liang; Paolini, John F. 分享 收藏
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Risankizumab治疗中重度特应性皮炎: 一项2期随机、双盲、安慰剂对照研究 Tyring, Stephen K. K.; Rich, Phoebe; Tada, Yayoi; Beeck, Stefan; Messina, Izabella; Liu, Jie; Huang, Xiaohong; Shumack, Stephen 分享 收藏
分享 收藏
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study Blauvelt, Andrew; Pariser, David M.; Tyring, Stephen; Bagel, Jerry; Alexis, Andrew F.; Soung, Jennifer; Armstrong, April W.; Muscianisi, Elisa; Kianifard, Farid; Steadman, Jennifer; Sarkar, Rajendra Prasad; Garcet, Sandra; Krueger, James G. 分享 收藏
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial tapinarof乳膏治疗斑块状银屑病的一年安全性和有效性: 来自PSOARING 3试验的结果 Strober, Bruce; Gold, Linda Stein; Bissonnette, Robert; Armstrong, April W.; Kircik, Leon; Tyring, Stephen K.; Piscitelli, Stephen C.; Brown, Philip M.; Rubenstein, David S.; Tallman, Anna M.; Lebwohl, Mark G. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trial Secukinumab在成人斑块状银屑病患者中通过2毫升自动注射器给药后显示出疗效,安全性和耐受性: 来自成熟,随机,安慰剂对照试验的52周结果 Sigurgeirsson, Bardur; Browning, John; Tyring, Stephen; Szepietowski, Jacek C.; Rivera-Diaz, Raquel; Effendy, Isaak; Keefe, Deborah; Bruin, Gerard; Paguet, Bertrand; Fu, Rong; Hampele, Isabelle; Reinhardt, Maximilian; Patekar, Manmath 分享 收藏
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG Jalili, A.; Calzavara-Pinton, P.; Kircik, L.; Lons-Danic, D.; Pink, A.; Tyring, S.; de la Cueva, P.; Gooderham, M.; Segaert, S.; Nyholm, N.; Thoning, H.; Petersen, B.; Thaci, D. 分享 收藏
分享 收藏
分享 收藏